OptimizeRx Corporation (OPRX)

OptimizeRx Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	109.43	92.13	71.52	62.45	61.29
Revenue Growth (YoY)	18.78%	28.81%	14.53%	1.89%	41.51%
Cost of Revenue	35.83	32.75	28.62	23.48	25.65
Gross Profit	73.6	59.38	42.9	38.97	35.64
Selling, General & Admin	57.21	61.27	58.02	49.24	33.19
Depreciation & Amortization Expenses	4.33	4.33	2.4	2.02	2.09
Other Operating Expenses	0.37	7.49	8.88	-	-
Total Operating Expenses	61.9	73.08	69.3	51.26	35.28
Operating Income	11.69	-13.71	-26.4	-12.29	0.36
Interest Income	0.35	0.33	2.19	0.85	0.02
Interest Expense	-5.29	-6.16	-1.45	-	-
Other Non-Operating Income (Expense)	0.2	0.15	0.5	-	-
Total Non-Operating Income (Expense)	-4.74	-5.68	1.24	0.85	0.02
Pretax Income	6.95	-19.39	-25.16	-11.44	0.38
Provision for Income Taxes	-1.82	-0.73	7.6	-	-
Net Income	5.13	-20.11	-17.57	-11.44	0.38
Net Income to Common	5.13	-20.11	-17.57	-11.44	0.38
Shares Outstanding (Basic)	19	18	17	18	17
Shares Outstanding (Diluted)	19	18	17	18	18
Shares Change (YoY)	3.86%	6.82%	-3.71%	0.53%	19.30%
EPS (Basic)	0.28	-1.10	-1.03	-0.64	0.02
EPS (Diluted)	0.27	-1.10	-1.03	-0.64	0.02
Shares Outstanding	18.76	18.45	18.15	17.15	17.86
Free Cash Flow	18.66	4.78	-7.33	10.57	0.63
Free Cash Flow Growth	290.56%	-	-	1589.76%	-
Free Cash Flow Per Share	0.98	0.26	-0.43	0.59	0.04
Gross Margin	67.25%	64.45%	59.98%	62.40%	58.14%
Operating Margin	10.69%	-14.88%	-36.91%	-19.68%	0.59%
Profit Margin	4.69%	-21.83%	-24.56%	-18.32%	0.62%
FCF Margin	17.05%	5.19%	-10.24%	16.93%	1.02%
EBITDA	16.02	-9.38	-24	-10.27	2.33
EBITDA Margin	14.64%	-10.18%	-33.56%	-16.44%	3.80%
EBIT	11.69	-13.71	-26.4	-12.29	0.36
EBIT Margin	10.69%	-14.88%	-36.91%	-19.68%	0.59%
Effective Tax Rate	-26.16%	3.74%	-30.19%	0.00%	0.00%

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q